QUCY earnings analysis
What we found in QUCY's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The extracted 10-Q does not provide current-period revenue, margins, cash flow, balance-sheet figures, segment results, or quantitative guidance, so operating performance versus the prior period and prior year cannot be assessed. The principal disclosed signal is a material weakness that made disclosure controls ineffective as of June 30, 2026. Management is pursuing an AI, drone, cybersecurity, quantum, and defense-related transition, but the filing highlights execution, licensing, manufacturing, financing, and dilution risks.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Material weakness disclosed
- Management concluded disclosure controls were not effective as of June 30, 2026 because of a material weakness in internal control over financial reporting.
- All 11 AGM proposals approved
- The AGM had 13,244,033 shares present or represented by proxy, and all 11 proposals submitted to shareholders were approved.
- Share issuance authority extended
- Shareholders approved extending the Board’s authorization to issue shares and grant subscription rights, with 5,981,752 votes for and 350,705 against.
- Remediation planned
- The filing states that management expects to make future changes to internal controls to remediate the material weakness identified as of June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Financial reporting control weakness
- The company identifies a reasonable possibility that a material misstatement will not be prevented or detected on a timely basis. Historically, the control deficiencies resulted in several preliminary-financial-statement misstatements that were corrected or deemed immaterial.
- Dependence on licensed technology
- The company’s transition strategy depends on two specifically named third-party license arrangements—BP United and Project LightShift—and the filing cites milestones, field-of-use limits, funding conditions, sublicensing restrictions, exclusivity conditions, and termination provisions as potential constraints.
- Capital needs and dilution
- The company had 22,767,254 ordinary shares outstanding and 5,000,000 preferred shares outstanding as of June 1, 2026. The filing warns that future equity issuances, including transaction consideration, may dilute existing shareholders, while additional capital may be required for commercialization, manufacturing scale-up, and operations.
What they said about what is next.
No quantitative revenue or EPS outlook is provided in the extracted 10-Q. The filing discusses potential future capital needs but does not provide numeric guidance.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 15, 2026
- Quantum Cyber reported a net loss of $5,081,982 in Q1 2026, 2% wider than $5,002,891 a year earlier, although diluted EPS improved to negative $0.43 from negative $1.46 because weighted-average shares rose to 11,799,424…
- 10-K · March 31, 2026
- QUCY's 2025 financial trajectory showed cost and cash-burn improvement, but its commercial base contracted sharply: revenue declined 40% to $537,080 while gross margin rose to 73%. The post-year-end strategy is a…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing QUCY makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever